Description
Introducing Duovir Tablets, a trusted combination therapy for the management of HIV/AIDS, proudly manufactured by Cipla Ltd. Each Duovir tablet contains the potent antiretroviral agents Lamivudine and Zidovudine in carefully balanced strengths, offering comprehensive treatment for individuals living with HIV.
Key Features:
- Dual Antiretroviral Action: Duovir Tablets combine the antiretroviral medications Lamivudine (150 mg) and Zidovudine (300 mg), which work synergistically to inhibit the replication of the HIV virus, thereby reducing viral load and slowing disease progression.
- Proven Efficacy: Backed by extensive clinical research and real-world use, Duovir has demonstrated robust efficacy in suppressing viral replication, preserving immune function, and improving clinical outcomes in HIV-infected individuals.
- Optimal Strength: With Lamivudine 150 mg and Zidovudine 300 mg in each tablet, Duovir offers a balanced combination of active ingredients, ensuring potent antiretroviral activity while minimizing the risk of resistance development.
- Manufactured by Cipla Ltd.: As a leading global pharmaceutical company known for its commitment to quality and innovation, Cipla Ltd. ensures that every Duovir tablet meets stringent quality standards, providing patients and healthcare professionals with confidence in their treatment choice.
- Patient-Friendly Formulation: Duovir Tablets are formulated for ease of administration, allowing for convenient intake without compromising efficacy. The tablet form ensures precise dosing, facilitating accurate treatment delivery and enhancing treatment adherence.
For individuals living with HIV/AIDS, Duovir Tablets offer a reliable and effective treatment option, empowering patients to manage their condition and improve quality of life.
**Important Note: Duovir Tablets (Lamivudine & Zidovudine) should only be used under the supervision of a qualified healthcare professional experienced in the management of HIV/AIDS. Dosage and treatment duration should be determined based on individual patient factors, including viral load, CD4 cell count, and treatment history. Compliance with prescribed treatment regimens is crucial for optimal therapeutic outcomes.
Reviews
There are no reviews yet.